Browse Category

Investment Opportunities News 24 September 2025 - 21 October 2025

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa’s stock story is a mix of bullish projects and market risks. The recent government-backed gallium plant (critical mineral for tech and defense) is a major positive, potentially diversifying Alcoa’s business beyond

21 October 2025

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

CRDO’s Wild Ride on AI Hype Credo (NASDAQ: CRDO) has become one of 2025’s hottest AI infrastructure stocks. The company makes advanced cables and chips that connect GPUs inside AI supercomputers. In

19 October 2025

Artificial Intelligence · Emerging Technologies · Investment Opportunities · NASDAQ:CRDO · Stock Market · Tech Partnerships

USA Rare Earth’s Meteoric Rise: The Pre-Revenue Mining Stock Targeting $30+ amid China Tensions

1. Company Overview: USAR’s Mine-to-Magnet Strategy USA Rare Earth, Inc. (Nasdaq: USAR) is a development-stage critical minerals company aimed at creating a fully domestic rare-earth supply chain. Its flagship asset is the

13 October 2025

Investment Opportunities · Market Trends · Mining Stocks · NASDAQ:USAR · Rare Earths · US-China Relations

Protagonist Therapeutics (PTGX) Skyrockets on J&J Buyout Buzz Amid Clinical Breakthroughs

Recent News and Corporate Developments J&J Buyout Buzz: The biggest news propelling Protagonist’s stock is the report that Johnson & Johnson is in talks to acquire Protagonist reuters.com. On October 10, 2025, The Wall Street

10 October 2025

Biotech Stocks · Clinical Trials · Investment Opportunities · Mergers & Acquisitions · NASDAQ:PTGX · Pharmaceutical Industry

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Quick Facts (as of 8 Oct 2025) Recent Performance and News Phase 1 data fuels rally Intellia’s October rally was triggered by longer‑term Phase 1 results for nexiguran ziclumeran (nex‑z), an in‑vivo CRISPR therapy for transthyretin

8 October 2025

Biotechnology · Company Analysis · Gene Editing · Investment Opportunities · NASDAQ:NTLA · Stocks

DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Key facts (Sept. 25–26, 2025) In‑depth report What happened, and why it matters Datavault AI — the former WiSA Technologies that rebranded in February 2025 — secured a headline‑grabbing $150 million commitment

26 September 2025

Artificial Intelligence · Cryptocurrency · Investment Opportunities · Penny Stocks · Stock Market · Technology News

Peabody Energy’s 2025 Coal Comeback: Big Buybacks, Booming Demand, and a Surging Stock

Peabody Energy (BTU) Stock Overview and Industry Insights as of September 24, 2025 Peabody Energy at a Glance in 2025 Peabody Energy Corp. is America’s largest coal producer, mining thermal coal for power

24 September 2025

Coal Industry · Energy Companies · Investment Opportunities · Market Trends · Stock Buybacks · Stock Market

Go toTop